Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Schoonjans

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|April 18, 2000
Thiazolidinediones: an updateK Schoonjans, J Auwerx
Critical Reviews in Clinical Laboratory Sciences|January 1, 1992
Lipoprotein lipase: recent contributions from molecular biologyJ Auwerx, P Leroy, K Schoonjans
Biochimica Et Biophysica Acta|July 26, 1996
The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiationK Schoonjans, B Staels, J Auwerx
Current Opinion in Lipidology|March 27, 2001
Xol INXS: role of the liver X and the farnesol X receptorsE Fayard, K Schoonjans, J Auwerx
Journal of Lipid Research|May 1, 1996
Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expressionK Schoonjans, B Staels, J Auwerx
Oncogene|June 10, 2010
Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibilityE H Jeninga, K Schoonjans, J Auwerx
Gastroenterologie Clinique Et Biologique|May 7, 2010
Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-alcoholic fatty liver diseaseT W H Pols, J Auwerx, K Schoonjans
European Journal of Biochemistry|September 1, 1993
Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferationK Schoonjans, B Staels, P Grimaldi, et al.
Current Opinion in Lipidology|June 1, 1997
Peroxisome proliferator-activated receptors, orphans with ligands and functionsK Schoonjans, G Martin, B Staels, et al.
Biochimica Et Biophysica Acta|December 9, 2000
Sterols and gene expression: control of affluenceK Schoonjans, C Brendel, D Mangelsdorf, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|April 18, 2000
Thiazolidinediones: an updateK Schoonjans, J Auwerx
Critical Reviews in Clinical Laboratory Sciences|January 1, 1992
Lipoprotein lipase: recent contributions from molecular biologyJ Auwerx, P Leroy, K Schoonjans
Biochimica Et Biophysica Acta|July 26, 1996
The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiationK Schoonjans, B Staels, J Auwerx
Current Opinion in Lipidology|March 27, 2001
Xol INXS: role of the liver X and the farnesol X receptorsE Fayard, K Schoonjans, J Auwerx
Journal of Lipid Research|May 1, 1996
Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expressionK Schoonjans, B Staels, J Auwerx
Oncogene|June 10, 2010
Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibilityE H Jeninga, K Schoonjans, J Auwerx
Gastroenterologie Clinique Et Biologique|May 7, 2010
Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-alcoholic fatty liver diseaseT W H Pols, J Auwerx, K Schoonjans
European Journal of Biochemistry|September 1, 1993
Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferationK Schoonjans, B Staels, P Grimaldi, et al.
Current Opinion in Lipidology|June 1, 1997
Peroxisome proliferator-activated receptors, orphans with ligands and functionsK Schoonjans, G Martin, B Staels, et al.
Biochimica Et Biophysica Acta|December 9, 2000
Sterols and gene expression: control of affluenceK Schoonjans, C Brendel, D Mangelsdorf, et al.
Pageof 4